Total admissions | 92 | ||
Excluded (no symptoms) | 17 | ||
Non-EVD Number (%) | EVD Number (%) | P value | |
Included patients | 44 (58.7) | 31 (41.3) | |
Sex | |||
Male | 36 (82) | 14 (45.1) | |
Female | 8 (18) | 17 (54.8) | 0.001 |
Age (years) | |||
Median (1–3 Q) | 40 (23–48) | 30 (17–40) | 0.095 |
Range (months-years) | 0–80 | 0–85 | |
History of contact with an Ebola patient | |||
Yes | 16 (36.3) | 23 (74.2) | <0.001 |
No | 23 (52.3) | 0 (−) | |
Unknown | 5 (11.3) | 8(25.8) | |
Suspect criteria | |||
Contact + Fever | 10 (22.7) | 15 (48.4) | 0.026 |
Contact + 3 symptoms | 8 (18) | 21 (67.7) | <0.001 |
Fever + 3 symptoms | 22 (50) | 18 (58) | 0.639 |
Bleeding | 0 (−) | 11 (35.5) | <0.001 |
Any WHO criterion | 26 (59) | 27 (87) | 0.01 |
Onset symptoms (days) | |||
Median (1–3 Q) | 2(1–6) | 3 (1–5) | 0.564 |
Stay length (days) | |||
Median (1–3 Q) | 4 (2–6) | 7(3–12) | 0.004 |
State at discharge | |||
Alive | 39 (88.6) | 13 (42) | <0.001 |
Dead | 5 (11.4) | 18 (58) |